Campora E - Search Results

1

Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer.

Pronzato P, Campora E, Amoroso D, Bertelli G, Botto F, Conte PF, Sertoli MR, Rosso R. Pronzato P, et al. Among authors: campora e. Am J Clin Oncol. 1989 Dec;12(6):481-5. doi: 10.1097/00000421-198912000-00004. Am J Clin Oncol. 1989. PMID: 2589228

2

Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.

Campora E, Pronzato P, Amoroso D, Bertelli GF, Venturini M, Baldini E, Brunetti I, Sertoli MR, Conte P, Rosso R. Campora E, et al. Anticancer Res. 1992 Sep-Oct;12(5):1555-8. Anticancer Res. 1992. PMID: 1444221

3

Mitoxantrone and mitomycin C as second-line treatment for advanced breast cancer.

Repetto L, Miglietta L, Gardin G, Naso C, Giudici S, Merlini L, Queirolo P, Campora E, Pronzato P, Rosso R. Repetto L, et al. Among authors: campora e. Ann Oncol. 1992 Feb;3(2):165-6. doi: 10.1093/oxfordjournals.annonc.a058135. Ann Oncol. 1992. PMID: 1606088 Free article.

4

Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.

Campora E, Baldini E, Rubagotti A, Chiara S, Bruzzi P, Sertoli MR, Rosso R. Campora E, et al. J Chemother. 1990 Oct;2(5):336-9. doi: 10.1080/1120009x.1990.11739039. J Chemother. 1990. PMID: 2090773 Clinical Trial.

5

Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look.

Bruzzone M, Repetto L, Chiara S, Campora E, Conte PF, Orsatti M, Vitale V, Rubagotti A, Rosso R. Bruzzone M, et al. Among authors: campora e. Gynecol Oncol. 1990 Sep;38(3):392-5. doi: 10.1016/0090-8258(90)90080-5. Gynecol Oncol. 1990. PMID: 2227553 Clinical Trial.

6

Randomized cooperative study of perioperative chemotherapy in breast cancer.

Sertoli MR, Bruzzi P, Pronzato P, Queirolo P, Amoroso D, Del Mastro L, Venturini M, Vigani A, Bertelli G, Campora E, et al. Sertoli MR, et al. Among authors: campora e. J Clin Oncol. 1995 Nov;13(11):2712-21. doi: 10.1200/JCO.1995.13.11.2712. J Clin Oncol. 1995. PMID: 7595729 Clinical Trial.

7

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.

Gardin G, Alama A, Rosso R, Campora E, Repetto L, Pronzato P, Merlini L, Naso C, Camoriano A, Meazza R, et al. Gardin G, et al. Among authors: campora e. Breast Cancer Res Treat. 1994;32(3):311-8. doi: 10.1007/BF00666008. Breast Cancer Res Treat. 1994. PMID: 7865857

8

Ondansetron and dexamethasone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses.

Campora E, Giudici S, Merlini L, Rubagotti A, Rosso R. Campora E, et al. Am J Clin Oncol. 1994 Dec;17(6):522-6. Am J Clin Oncol. 1994. PMID: 7977174 Clinical Trial.

9

[Tropisetron versus ondansetron in the prevention and control of emesis in patients undergoing chemotherapy with FAC/FEC for metastatic or surgically treated breast carcinoma].

Campora E, Simoni C, Rosso R. Campora E, et al. Minerva Med. 1994 Jan-Feb;85(1-2):25-31. Minerva Med. 1994. PMID: 8152575 Clinical Trial. Italian.

10

The impact of chemotherapy on the quality of life of breast cancer patients.

Campora E, Naso C, Vitullo MT, Giudici S, Camoirano A, Repetto L, Rosso R. Campora E, et al. J Chemother. 1992 Feb;4(1):59-63. doi: 10.1080/1120009x.1992.11739141. J Chemother. 1992. PMID: 1383437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters